Cabaletta Bio Inc share price logo

Cabaletta Bio Inc Share Price

NASDAQ: CABA

Small Cap

$2.50

-0.25

(-8.94%)

as on

Cabaletta Bio Inc Stock Performance

as on October 30, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $2.46
    $2.75
    downward going graph

    1.60%

    Downside

    10.00%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.99
    $5.46
    downward going graph

    60.57%

    Downside

    118.40%

    Upside

    downward going graph

Cabaletta Bio Inc share price movements today

Previous Close
$2.74
Open
$2.74
Volume
2.6M
Day's Low - High
$2.46 - $2.75
52 Week Low - High
$0.99 - $5.46

Cabaletta Bio Inc Historical Returns

1 Month Return
+ 6.84 %
3 Month Return
+ 60.26 %
1 Year Return
-34.04 %
3 Year Return
+ 46.2 %
5 Year Return
-78.39 %

Cabaletta Bio Inc Stock Fundamentals & Key Indicators

Check Cabaletta Bio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$255.2M

EPS (TTM)

-2.1475

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-148.0M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-76.34%

Cabaletta Bio Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cabaletta Bio Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Cabaletta Bio Inc image
Cabaletta Bio Inc
BUY$255.2M-78.39%NA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$62.4B291.63%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$36.4BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$108.3B100.24%30.0231.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$69.4B20.12%15.732.13%

Stock Returns calculator for Cabaletta Bio Inc Stock including INR - Dollar returns

The Cabaletta Bio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Cabaletta Bio Inc investment value today

Current value as on today

₹71,024

Returns

₹28,976

(-28.98%)

Returns from Cabaletta Bio Inc Stock

₹34,037 (-34.04%)

Dollar Returns*

₹5,061 (+5.06%)

Analyst Recommendation on Cabaletta Bio Inc Stock

Based on 17 analysts

BUY

94.12%

Buy

5.88%

Hold

0.00%

Sell

Based on 17 analysts, 94.12% of analysts recommend a 'BUY' rating for Cabaletta Bio Inc. Average target price of $12.25

Cabaletta Bio Inc Share Price Target

Get share price movements and forecasts by analysts on Cabaletta Bio Inc.

What analysts predicted

79.59%UPSIDE

Target Price

$12.25

Current Price

$2.5

Analyzed by

17 Analysts

Target

$12.25

Cabaletta Bio Inc target price $12.25, a slight upside of 79.59% compared to current price of $2.5. According to 17 analysts rating.

Cabaletta Bio Inc Stock’s Investor Sentiment and Interest

Search interest for Cabaletta Bio Inc Stock has increased by 146% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:146% versus previous 30 day period

Cabaletta Bio Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
4
-
-
-
1
-
-
Gross Profit
0
0
0
3
0
0
0
0
0
0
Operating Income
-16
-15
-18
-23
-28
-30
-33
-33
-37
-45
EBITDA
-16
-15
-18
-22
-27
-29
-32
-23
-37
-44
Interest Expense
1
-
-
1
-
-
-
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-15
-14
-16
-20
-25
-27
-30
-32
-35
-45
Income Tax Expense
-1
0
0
1
0
-
-
0
-
-
Net Income
-15
-14
-16
-20
-25
-27
-30
-32
-35
-45
Net Profit Margin
0.00%
0.00%
0.00%
-520.85%
0.00%
0.00%
0.00%
-1989.38%
0.00%
0.00%

Cabaletta Bio Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
-
-
Gross Profit
-
0
-
0
-3
-1
-4
Operating Income
-6
-18
-33
-46
-54
-74
-125
EBITDA
-12
-18
-33
-45
-52
-73
-125
Interest Expense
-
-
0
0
1
-
0
Depreciation
-
0
0
0
1
1
1
Income Before Tax
-12
-16
-33
-46
-52
-67
-115
Income Tax Expense
0
-1
0
0
-1
-
-
Net Income
-12
-15
-32
-45
-51
-67
-115
Net Profit Margin
0.00%
0.00%
-324910000000.00%
0.00%
0.00%
0.00%
0.00%

Cabaletta Bio Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-14
-16
-20
-25
-27
-30
-32
-35
-45
Operating Cash Flow
-11
-12
-16
-23
-20
-20
-23
-30
-30
Investing Cash Flow
-48
0
1
0
23
12
12
0
-49
Financing Cash Flow
94
0
93
6
0
0
4
0
93
Change in Cash
34
-12
77
-17
3
-8
-6
-32
13

Cabaletta Bio Inc Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-12
-16
-33
-46
-52
-67
-115
Operating Cash Flow
-4
-16
-26
-34
-46
-53
-88
Investing Cash Flow
0
0
-7
5
-27
-22
47
Financing Cash Flow
37
119
0
48
32
187
11
Change in Cash
33
103
-34
20
-40
111
-29

Global Institutional Holdings in Cabaletta Bio Inc

Funds
Holdings
Bain Capital Life Sciences Investors, LLC
10.58%
Adage Capital Partners Gp LLC
9.65%
T. Rowe Price Investment Management,Inc.
7.43%
Jennison Associates LLC
6.58%
Cormorant Asset Management, LLC
5.47%
See all

Insights on Cabaletta Bio Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, CABA stock has moved up by 60.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 135.5% return, outperforming this stock by 89.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 71.1% return, outperforming this stock by 105.1%

About Cabaletta Bio Inc

cabaletta bio, inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered t cell therapies for patients with b cell-mediated autoimmune diseases. its proprietary technology utilizes chimeric autoantibody receptor (caar) t cells that are designed to selectively bind and eliminate b cells, which produce disease-causing autoantibodies or pathogenic b cells. the company's lead product candidate is dsg3-caart, which is in phase i clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease, and hemophilia a with factor viii alloantibodies. its product candidate pipeline also include musk-caart, a preclinical stage product to treat a subset of patients with myasthenia gravis; fviii-caart, a discovery stage product to treat a subset of patients with hemophilia a; and dsg3/1-caart, a discovery stage product for the treatment of mucocutaneous pemphigus vulgaris. cabaletta bio, inc. has a collaboration with the un
OrganisationCabaletta Bio Inc
Headquarters2929 Arch Street, Philadelphia, PA, United States, 19104
IndustryHealth Technology
CEODr. Steven A. Nichtberger M.D.
E-voting on sharesClick here to vote

Key Management of Cabaletta Bio Inc

Name

Title

Dr. Samik Basu M.D.

Chief Scientific Officer

Mr. Michael Gerard J.D.

General Counsel & Secretary

Dr. David J. Chang FACR, M.D., M.P.H.

Chief Medical Officer

Dr. Gwendolyn K. Binder Ph.D.

President of Science & Technology

Dr. Michael C. Milone M.D., Ph.D.

Co-Founder & Co-Chair of Scientific Advisory Board

Dr. Qing Sarah Yuan Ph.D.

Chief Technology Officer

Ms. Heather Harte-Hall M.Sc.

Chief Compliance Officer

Dr. Steven A. Nichtberger M.D.

Co-Founder, Chairman, CEO & President

Dr. Aimee Payne M.D., Ph.D.

Co-Founder & Co-Chair of Scientific Advisory Board

Mr. Anup Marda M.B.A.

Chief Financial Officer

FAQs

What is Cabaletta Bio Inc share price today?

Cabaletta Bio Inc share price today is $2.5 as on at the close of the market. Cabaletta Bio Inc share today touched a day high of $2.75 and a low of $2.46.

What is the 52 week high and 52 week low for Cabaletta Bio Inc share?

Cabaletta Bio Inc share touched a 52 week high of $5.46 on and a 52 week low of $0.99 on . Cabaletta Bio Inc stock price today i.e. is closed at $2.5,which is 54.21% down from its 52 week high and 153.63% up from its 52 week low.

What is Cabaletta Bio Inc's market capitalisation today?

Cabaletta Bio Inc market capitalisation is $0.00T as on .

How to invest in Cabaletta Bio Inc Stock (CABA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cabaletta Bio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cabaletta Bio Inc Shares that will get you 0.6000 shares as per Cabaletta Bio Inc share price of $2.5 per share as on October 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Cabaletta Bio Inc Stock (CABA) from India?

Indian investors can start investing in Cabaletta Bio Inc (CABA) shares with as little as ₹88.178 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.78 in Cabaletta Bio Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Cabaletta Bio Inc share’s latest price of $2.5 as on October 30, 2025 at 1:29 am IST, you will get 4.0000 shares of Cabaletta Bio Inc. Learn more about fractional shares .

What are the returns that Cabaletta Bio Inc has given to Indian investors in the last 5 years?

Cabaletta Bio Inc stock has given -78.39% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?